References
- Alldred SK, Deeks JJ, Guo B, et al. Second trimester serum tests for Down’s syndrome screening. Cochrane Database of Syst Rev (Online) 2012;6:CD009925
- Bartha JL, Illanes S, Abdel-Fattah SA, et al. Maternal serum alpha-fetoprotein, fetal middle cerebral artery blood flow velocity and fetal haemoglobin in pregnancies at risk of fetal anaemia. Prenat Diagn 2006;26:101–4
- Komischke K, Searle K, Enders G. Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications. Prenat Diagn 1997;17:1039–46
- Ong CY, Lee CP, Leung KY, et al. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies. Obstet Gynecol 2006;108:651–5
- Tongprasert F, Srisupundit K, Luewan S, et al. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart’s disease. J Matern Fetal Neonatal Med 2013;26:146–9
- Lambert-Messerlian GM, Saller DN, Jr Tumber MB, et al. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops. Prenat Diagn 1998;18:1061–7
- Fitzgerald B, Levytska K, Kingdom J, et al. Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. Placenta 2011;32:339–45
- Promsonthi P, Panburana P, Kadegasem P, et al. Inhibin-A levels between 14 and 20 weeks of gestation in Thai women. J Obstet Gynaecol Res 2012;38:118–21
- Tongprasert F, Tongsong T, Wanapirak C, et al. Experience of the first 50 cases of cordocentesis after training with model. J Med Assoc Thai 2005;88:728–33
- Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9–14
- Wald NJ, Densem JW, George L, et al. Prenatal screening for Down’s syndrome using inhibin-A as a serum marker. Prenat Diagn 1996;16:143–53
- Aitken DA, Wallace EM, Crossley JA, et al. Dimeric inhibin A as a marker for Down’s syndrome in early pregnancy. N Engl J Med 1996;334:1231–6
- Benn PA, Egan JF, Ingardia CJ. Extreme second-trimester serum analyte values in Down syndrome pregnancies with hydrops fetalis. J Matern Fetal Neonatal Med 2002;11:262–5
- Saller DN, Jr Canick JA, Oyer CE. The detection of non-immune hydrops through second-trimester maternal serum screening. Prenat Diagn 1996;16:431–5
- Saller DN, Jr Canick JA, Schwartz S, et al. Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome. Am J Obstet Gynecol 1992;167:1021–4
- Spencer K, Liao AW, Skentou H, et al. Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000;20:495–9
- Cuckle H, Sehmi I, Jones R. Maternal serum inhibin A can predict pre-eclampsia. Br J Obstet Gynaecol 1998;105:1101–3
- Srisupundit K, Piyamongkol W, Tongsong T. Identification of fetuses with hemoglobin Bart’s disease using middle cerebral artery peak systolic velocity. Ultrasound Obstet Gynecol 2009;33:694–7
- Tongsong T, Wanapirak C, Sirichotiyakul S, et al. Sonographic markers of hemoglobin Bart disease at midpregnancy. J Ultrasound Med 2004;23:49–55